SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,126 | +5.0% | 34,035 | -0.8% | 0.11% | +9.7% |
| Q2 2023 | $3,929 | -7.4% | 34,310 | +11.5% | 0.10% | -10.4% |
| Q1 2023 | $4,243 | -17.1% | 30,785 | -22.0% | 0.12% | -19.6% |
| Q4 2022 | $5,117 | -99.9% | 39,490 | -1.7% | 0.14% | +7.5% |
| Q3 2022 | $4,443,000 | +44.6% | 40,190 | -2.0% | 0.13% | +43.0% |
| Q2 2022 | $3,073,000 | -5.0% | 40,990 | -1.0% | 0.09% | +6.9% |
| Q1 2022 | $3,235,000 | -12.8% | 41,415 | +0.5% | 0.09% | 0.0% |
| Q4 2021 | $3,709,000 | +18.8% | 41,190 | +22.0% | 0.09% | +7.4% |
| Q3 2021 | $3,123,000 | +49.4% | 33,765 | +25.6% | 0.08% | +55.8% |
| Q2 2021 | $2,090,000 | -26.4% | 26,890 | -29.4% | 0.05% | -29.7% |
| Q1 2021 | $2,839,000 | -56.3% | 38,090 | 0.0% | 0.07% | -58.0% |
| Q4 2020 | $6,494,000 | -19.0% | 38,090 | -48.2% | 0.18% | +46.7% |
| Q3 2020 | $8,015,000 | +31.2% | 73,480 | +92.9% | 0.12% | -37.5% |
| Q2 2020 | $6,107,000 | +63.9% | 38,090 | 0.0% | 0.19% | +36.2% |
| Q1 2020 | $3,726,000 | +25.0% | 38,090 | +65.0% | 0.14% | +65.9% |
| Q4 2019 | $2,980,000 | +11.8% | 23,090 | -34.8% | 0.08% | +3.7% |
| Q3 2019 | $2,666,000 | -38.1% | 35,390 | +24.8% | 0.08% | -38.3% |
| Q2 2019 | $4,310,000 | +63.9% | 28,365 | +28.6% | 0.13% | +60.2% |
| Q1 2019 | $2,630,000 | +55.6% | 22,065 | +42.4% | 0.08% | +53.7% |
| Q4 2018 | $1,690,000 | -32.5% | 15,490 | 0.0% | 0.05% | -15.6% |
| Q3 2018 | $2,502,000 | -0.4% | 15,490 | -18.5% | 0.06% | -1.5% |
| Q2 2018 | $2,513,000 | +23.9% | 19,015 | -30.5% | 0.06% | +30.0% |
| Q1 2018 | $2,028,000 | +33.2% | 27,375 | 0.0% | 0.05% | +38.9% |
| Q4 2017 | $1,523,000 | +1.1% | 27,375 | -17.6% | 0.04% | -2.7% |
| Q3 2017 | $1,507,000 | +109.0% | 33,225 | +55.3% | 0.04% | +105.6% |
| Q2 2017 | $721,000 | – | 21,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |